🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Triple-negative breast cancer (TNBC) is among the most aggressive and letha...
Status
Recruiting
Location
Fondazione IRCCS San Gerardo Dei Tintori
Start Date
2025-03-06
Trial ID
NCT06690840
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
The purpose of this study is to investigate the role of brain receptors cal...
Status
Completed
Location
National Institute of Mental Health (NIMH)
Start Date
2002-01
Trial ID
NCT00029627
Treatments Being Tested
Development of an active second-line treatment option for metastatic breast...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-25
Trial ID
NCT04143906
Treatments Being Tested
This is a prospective, randomized, double-blind, placebo-controlled explora...
Status
Recruiting
Location
McMaster University
Start Date
2022-12-01
Trial ID
NCT05576038
Treatments Being Tested
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Hospital Italiano de Buenos Aires
Start Date
1999-10
Trial ID
NCT00004218
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
Many people with MS report sleep disturbances. However, objective data on s...
Status
Completed
Location
University of California, San Francisco
Start Date
2019-09-23
Trial ID
NCT04035889
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested